Literature DB >> 890697

Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma.

G D Malkasian, D G Decker, E O Jorgensen, J H Edmonson.   

Abstract

Entities:  

Keywords:  Cancer; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Agents--therapeutic use; Diseases; Family Planning; Medroxyprogesterone Acetate--administraction and dosage; Medroxyprogesterone Acetate--side effects; Medroxyprogesterone Acetate--therapeutic use; Neoplasms; Oral Contraceptives; Ovarian Cancer; Research Methodology; Women

Mesh：

Substances：

Year:  1977        PMID： 890697

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  7 in total

Review 1.  Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Authors:  R M Canetta; S K Carter
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 2.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

3.  In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy.

Authors:  H M Runge; G Teufel; J Neulen; H Geyer; A Pfleiderer
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 4.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

5.  British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

6.  Optimal chemotherapy for ovarian carcinoma: discussion paper.

Authors:  H E Lambert
Journal:  J R Soc Med       Date:  1984-01       Impact factor: 18.000

7.  In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Authors:  A P Wilson; F E Neal
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.